Back to search

Clozapine: Current Status and Role in the Pharmacotherapy of Schizophrenia

Data up to Jan 2025

Published1996
Citations20
References56

Total Citations Per Year

Abstract

References (56)

The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia

1987 • 19,723 citations

Clozapine for the Treatment-Resistant Schizophrenic

1988 • 4,030 citations

The Quality of Life Scale: An Instrument for Rating the Schizophrenic Deficit Syndrome

1984 • 1,671 citations

Risperidone in the treatment of schizophrenia

1994 • 1,205 citations

Clozapine-Induced Agranulocytosis -- Incidence and Risk Factors in the United States

1993 • 948 citations

A Canadian Multicenter Placebo-Controlled Study of Fixed Doses of Risperidone and Haloperidol in the Treatment of Chronic Schizophrenic Patients

1993 • 884 citations

Neuroleptics and the Natural Course of Schizophrenia

1991 • 777 citations

Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia

1989 • 600 citations

Why Do Schizophrenic Patients Refuse to Take Their Drugs?

1974 • 584 citations

Significance of Neuroleptic Dose and Plasma Level in the Pharmacological Treatment of Psychoses

1988 • 554 citations

Effects of Six Months of Clozapine Treatment on the Quality of Life of Chronic Schizophrenic Patients

1990 • 351 citations

Treatment of the Neuroleptic-Nonresponsive Schizophrenic Patient

1992 • 332 citations

Schizophrenia: Scientific progress

1990 • 330 citations

D1- and D2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics

1989 • 322 citations

Risperidone versus haloperidol in the treatment of chronic schizophrenic inpatients: a multicentre double‐blind comparative study

1992 • 302 citations

Psychopharmacologic Treatment of Schizophrenia

1993 • 283 citations

A prospective study of clozapine in treatment-resistant schizophrenic patients

1989 • 269 citations

Clozapine: neuroleptic-induced EPS and tardive dyskinesia

1989 • 256 citations

Dimensions of Outcome with Clozapine

1992 • 256 citations

At Issue: Defining Treatment Refractoriness in Schizophrenia

1990 • 248 citations

General Pharmacology of Clozapine

1992 • 238 citations

Clozapine: guidelines for clinical management.

1989 • 230 citations

Functional Assessment in Rehabilitation

1986 • 229 citations

Cost effectiveness of clozapine in neuroleptic-resistant schizophrenia

1993 • 211 citations

Risperidone: clinical safety and efficacy in schizophrenia.

1992 • 208 citations

A Controlled Dose Comparison of Haloperidol in Newly Admitted Schizophrenic Patients

1990 • 187 citations

When Symptoms Persist: Choosing Among Alternative Somatic Treatments for Schizophrenia

1991 • 179 citations

A Prospective, Multicenter Study of Patients' Refusal of Antipsychotic Medication

1990 • 161 citations

Neuroleptic Plasma Levels

1991 • 153 citations

Depot neuroleptic therapy: an underutilized treatment option.

1992 • 147 citations

Clinical Efficacy of Clozapine in Treatment-Refractory Schizophrenia: An Overview

1992 • 145 citations

Treatment of neuroleptic-resistant schizophrenic relapse.

1993 • 127 citations

Clozapine-Associated Agranulocytosis: Risk and Aetiology

1992 • 123 citations

Antipsychotic Drugs

1977 • 121 citations

Treatment outcome with clozapine in tardive dyskinesia, neuroleptic sensitivity, and treatment-resistant psychosis.

1987 • 119 citations

Clozapine

1991 • 110 citations

Efficacy and adverse effects of clozapine in the treatment of schizophrenia and tardive dyskinesia ? a retrospective study of 387 patients

1989 • 107 citations

Clozapine: New research on efficacy and mechanism of action

1989 • 104 citations

Fluphenazine Dose, Clinical Response, and Extrapyramidal Symptoms During Acute Treatment

1990 • 99 citations

Clozapine pharmacology and tardive dyskinesia

1989 • 65 citations

A review of clozapine: An antipsychotic for treatment-resistant schizophrenia

1990 • 48 citations

Commentary: The Strategy and Value of Neuroleptic Drug Monitoring

1985 • 42 citations

Clozapine and D1/D2 Antagonism in Extrapyramidal Functions

1992 • 41 citations

Novel approaches to the pharmacotherapy of schizophrenia

1986 • 36 citations

Diagnostic confusion in treatment-refractory psychotic patients.

1992 • 32 citations

The use of clozapine in treatment-refractory schizophrenia

1993 • 17 citations

Clozapine in the Treatment of Refractory Schizophrenia: Canadian Policies and Clinical Guidelines*

1992 • 17 citations

Dosaging Patterns in Schizophrenia with Depot, Oral and Combined Neuroleptic Therapy

1993 • 13 citations

Ethical and Clinical Considerations in Selecting Patients Who Will Receive Clozapine

1990 • 11 citations

Reassessment of state hospital patients diagnosed with schizophrenia

1989 • 5 citations

Effect of atypical and typical antipsychotic drugs on neuropsychological functions in early-stage schizophrenic patients

1992 • 5 citations

Response to Fuchs

1994 • 3 citations

A pharmacoeconomic evaluation of clozapine in one patient.

1993 • 3 citations

Efficacy and tolerability of clozapine in the treatment of 425 schizophrenic patients

1991 • 3 citations

Differential effect of clozapine on psychopathology and cognitive dysfunction in treatment-resistant schizophrenics

1991 • 2 citations

Effects of clozapine on cognition in patients with schizophrenia

1991 • 1 citations

Cited By (0)

Loading...
Clozapine: Current Status and Role in the Pharmacotherapy of Schizophrenia (1996) – The Canadian Journal of Psychiatry | Metascience Observatory Explorer